Cyient DLM Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ohs1j5qygbmjcjzqjawvqxz7.pdf

Key Takeaways


Revenue: The Hole and the Rebuild

Krishna Bodanapu: "I believe the worst, if I may, is behind us, at least from a revenue perspective."

Margins: Quality Over Quantity

Rajendra Velagapudi: "whatever order book we have today, so based on the order book, margins are going to be better than what we had currently."

Order Book & Strategic Pipeline

Rajendra Velagapudi: "We expect revenues from these programs to begin within 2 years, supported by healthy gross margins and higher volumes. These engagements represent a significant long-term opportunity and are expected to meaningfully contribute to our financials from FY '28 onwards."

Build-to-Spec: The Margin Story


Balance Sheet & Working Capital

R. M. Subramanian: "We are net cash positive. So we have ability to go up to, from a pure working capital perspective, another INR350 crores to INR400 crores."

Tariffs & Geographic Exposure


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthPositive year-over-year growthQ4 FY26
FY'27 revenue growth20% to 25% growthFY'27
Order inflowReturn to Q1/Q2 levels (~₹500 crore)Q4 FY26
EBITDA marginSlightly more than Q3's double-digit levelQ4 FY26 and FY'27
Build-to-Spec mixDouble-digit percentage of revenueFY'27
Next-gen product revenueMeaningful contribution to financialsFY'28 onwards
Net working capitalNormalizationQ4 FY26 and beyond
Sales team impactNew hires to show order intakeWithin ~2 quarters

Key Metrics

MetricQ3 FY26
Revenue₹303.3 cr, 31.7% YoY decline
Order book₹2,350 cr, QoQ increase of ₹58.3 cr
Order intake₹387 cr
Book-to-bill ratio1.3x for Q3; 1.56x YTD
EBITDA (reported)₹27.5 cr, 9.1% of revenue
EBITDA (normalized)₹30.9 cr, 10.2% margin, 207 bps higher YoY
PAT (normalized)₹13.8 cr, 18.6% YoY decline; margin 4.6%, 73 bps higher YoY
PAT (reported)₹11.2 cr, 3.7% of revenue
Build-to-spec revenue mix~6% to 7% of FY26 revenue
New customer logos added2 (medical and industrial)
IPO proceeds utilized93.2% as of Dec 2025; working capital 97.2%, capex 15.4%
One-off: M&A evaluation expense$17.75 mn expensed in Q3
One-off: Wage code impact₹1.63 cr expensed in Q3
Balance sheet capacity for additional working capital₹350 cr to ₹400 cr
Regular capex run rate1% to 2% of revenue